ArticleNature communications2026
Canonical Notch2 signaling regulates development and maintenance of iron-recycling macrophages and iron homeostasis.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Red pulp macrophages (RPM) and bone marrow macrophages (BMM) are iron-recycling cells, involved in iron homeostasis and erythropoiesis. Here we show, by conditional deletion strategies using Cx3cr1Cre-mediated targeting to inactivate Notch signalling components in mice, that canonical Notch2 signalling regulates the development of RPM and BMM. Loss of functional Notch2, or its nuclear mediator Rbpj, impair RPM and BMM development and cause iron overload in the spleen and bone marrow. In the absence of Notch2, prototypic RPM genes are downregulated, which is accompanied by splenic extramedullary haematopoiesis and changes in splenic microarchitecture. Treatment of mice with an anti-Notch2 blocking antibody recapitulates the impaired erythrophagocyte and de novo extramedullary hematopoiesis phenotypes characteristic to the genetic model. Furthermore, early postnatal transfer of bone marrow and fetal liver progenitors rescues the defects in RPM and BMM in a Notch2-dependent manner, demonstrating the potential to restore defective tissue resident macrophage niches by Notch-competent progenitors. Thus, our study demonstrates that canonical Notch2 signalling is required for the development, maintenance, and function of iron-recycling macrophages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.